The global endoscopy devices market size was valued at USD 61.91 billion in 2025 and is projected to grow from USD 64.11 billion in 2026 to USD 84.82 billion by 2034, registering a CAGR of 3.56% during the forecast period from 2026 to 2034. North America dominated the endoscopy devices market with a market share of 42.5% in 2025.
Endoscopy devices are medical instruments used to visually examine, diagnose, and treat conditions within the body's internal organs and cavities through minimally invasive procedures. They typically include endoscopes, cameras, light sources, visualization systems, biopsy instruments, and therapeutic accessories. These devices enable healthcare professionals to obtain real-time images of internal structures and perform procedures such as tissue sampling, polyp removal, bleeding control, and minimally invasive surgery.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Assisted and Minimally Invasive Endoscopy Technologies
The endoscopy devices market trends are being driven by the rising demand for minimally invasive diagnosis and treatment, increasing cases of gastrointestinal and respiratory diseases, and advances in medical imaging. Hospitals and diagnostic centers are increasingly adopting high-definition, 4K, and flexible endoscopy systems to improve visualization and support more accurate procedures. Artificial intelligence (AI) is also gaining importance in endoscopy by helping physicians identify polyps, lesions, bleeding, and other abnormalities during real-time examinations. Single-use endoscopes are gaining attention as healthcare providers seek to reduce cross-contamination risks and simplify device reprocessing. In addition, capsule endoscopy, image-enhancement technologies, and robotic-assisted endoscopic systems are expanding the range of diagnostic and therapeutic procedures. Growing awareness of early cancer detection, particularly for colorectal and gastrointestinal cancers, is further encouraging the use of advanced endoscopic technologies across hospitals and specialized diagnostic centers.
These developments indicate that artificial intelligence, high-definition imaging, single-use endoscopes, capsule endoscopy, and minimally invasive procedures will remain the key endoscopy devices market trends, improving diagnostic accuracy, enhancing patient safety, and driving long-term growth across global healthcare systems.
Rising Prevalence of Gastrointestinal Disorders and Increasing Minimally Invasive Procedures
The endoscopy devices market is expanding due to the increasing prevalence of gastrointestinal, respiratory, and other chronic diseases requiring diagnostic and therapeutic procedures. Healthcare providers are increasingly adopting minimally invasive endoscopic techniques because they can reduce recovery time, hospital stays, and procedure-related complications compared with conventional surgery. Growing healthcare expenditure, an aging population, and continuous advancements in high-definition imaging and flexible endoscopy technologies are further accelerating demand. These developments are significantly contributing to endoscopy devices market growth as hospitals and specialty centers expand their diagnostic and therapeutic capabilities.
High Equipment Costs and Risk of Procedure-Related Infections
The endoscopy devices market faces challenges due to the high cost of advanced endoscopy systems, accessories, and equipment maintenance. Healthcare facilities must make significant investments in imaging systems, endoscopes, reprocessing equipment, and specialized training. In addition, inadequate cleaning and sterilization of reusable endoscopes can create infection risks, increasing the need for strict reprocessing protocols and quality control. Recent endoscopy devices market analysis indicates that these factors can limit adoption, particularly among smaller healthcare facilities and cost-sensitive markets.
Expansion of Single-Use Endoscopes and Advanced Imaging Technologies
The endoscopy devices market is expected to benefit from increasing adoption of single-use endoscopes, artificial intelligence-assisted imaging, and advanced visualization technologies. Disposable endoscopy devices can reduce cross-contamination risks and simplify reprocessing requirements, while AI-assisted systems can help clinicians identify abnormalities and improve diagnostic accuracy. Growing demand for minimally invasive procedures and increasing investments in ambulatory surgical centers are also creating significant growth opportunities. These developments are expected to strengthen the endoscopy devices market size by expanding access to advanced diagnostic and therapeutic procedures.
Ensuring Image Quality, Device Reliability, and Effective Reprocessing
The endoscopy devices market continues to face challenges related to maintaining high image quality, ensuring device reliability, and achieving effective sterilization and reprocessing of reusable equipment. Manufacturers must continuously improve visualization, maneuverability, durability, and ergonomic design while meeting stringent medical device safety requirements. The integration of artificial intelligence and digital imaging technologies also requires continuous investment in software development and clinical validation. According to recent endoscopy devices market reports, companies are investing in high-resolution imaging, AI-enabled detection technologies, single-use devices, and automated reprocessing solutions to improve procedural safety and strengthen long-term market competitiveness.
Request Customizationto receive a tailored report.
Endoscopes Segment is Projected to Register the Fastest Growth at a CAGR of 8.1%
The endoscopes segment is projected to register the fastest growth at a CAGR of 8.1% during 2026–2034. In 2025, the segment accounted for 39.8% of the global endoscopy devices market, with a value of USD 24.64 billion. Growth is driven by increasing adoption of minimally invasive procedures, rising prevalence of gastrointestinal and other chronic diseases, and growing demand for advanced diagnostic and therapeutic endoscopic procedures. Technological advancements in endoscope design and imaging capabilities continue to support the segment's growth.
The endoscopy visualization systems segment accounted for 25.4% of the market, with a value of USD 15.73 billion and a CAGR of 7.6%. Endoscopy visualization components represented 18.7% of the market, while operative devices accounted for 16.1% and are projected to grow at a CAGR of 8%. Increasing demand for high-quality visualization, improved procedural accuracy, and advanced operative capabilities continues to support these segments.
Outpatient Facilities Segment is Projected to Register the Fastest Growth at a CAGR of 8.6%
The outpatient facilities segment is projected to register the fastest growth at a CAGR of 8.6% during 2026–2034. In 2025, the segment accounted for 27.4% of the global endoscopy devices market, with a value of USD 16.96 billion. Growth is driven by the increasing shift toward outpatient and minimally invasive procedures, shorter hospital stays, lower treatment costs, and growing availability of advanced endoscopic technologies in ambulatory healthcare settings.
The hospitals segment dominated the market with a 72.6% share and a value of USD 44.95 billion. The strong position of hospitals is supported by their high volume of diagnostic and therapeutic endoscopic procedures, availability of specialized medical professionals, and extensive access to advanced endoscopy infrastructure. Hospitals continue to represent the primary end-use setting for complex and high-volume endoscopic procedures.
Speak to an Analystto discuss market opportunities.
North America endoscopy devices market accounted for 42.5% of the global market, reaching USD 26.31 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. The market is driven by increasing prevalence of gastrointestinal and other chronic diseases, growing demand for minimally invasive procedures, rising adoption of advanced endoscopic technologies, and increasing healthcare expenditure. Continuous innovation in imaging systems and therapeutic endoscopy devices continues to support regional market growth.
The US market was valued at USD 22.36 billion in 2025, making it the largest contributor in North America. Increasing demand for minimally invasive procedures, growing adoption of high-definition and advanced imaging technologies, rising healthcare investments, and expanding endoscopy procedures continue to drive market growth.
Canada's market reached USD 3.95 billion in 2025. Growing healthcare expenditure, increasing adoption of minimally invasive procedures, expanding access to advanced diagnostic technologies, and rising demand for gastrointestinal screening continue to support steady market expansion.
Europe endoscopy devices market accounted for 27.8% of the global market, reaching USD 17.21 billion in 2025, and is projected to grow at a CAGR of 7.1% during the forecast period. Rising prevalence of gastrointestinal diseases, increasing demand for minimally invasive treatments, expanding healthcare infrastructure, and growing adoption of advanced endoscopic systems continue to strengthen regional market growth. Increasing investments in innovative visualization and therapeutic technologies further support market expansion.
The UK market was valued at USD 3.44 billion in 2025. Increasing demand for early disease detection, growing adoption of minimally invasive procedures, expanding endoscopy screening programs, and rising investments in advanced healthcare technologies continue to support market growth.
Germany market accounted for USD 4.82 billion in 2025. Strong healthcare infrastructure, increasing demand for minimally invasive procedures, growing adoption of advanced endoscopic imaging, and rising investments in medical technology continue to drive market expansion.
Asia Pacific endoscopy devices market accounted for 21.6% of the global market, reaching USD 13.37 billion in 2025, and is projected to grow at a CAGR of 9.2% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of gastrointestinal diseases, growing healthcare expenditure, and rising adoption of minimally invasive procedures continue to accelerate regional market growth. Expanding access to advanced diagnostic and therapeutic endoscopy technologies further strengthens market expansion.
China's market accounted for USD 5.61 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing demand for gastrointestinal screening, growing adoption of minimally invasive procedures, and rising investments in advanced medical devices continue to drive market expansion.
Japan's market generated USD 2.41 billion in 2025. Increasing demand for early cancer detection, growing elderly population, expanding adoption of advanced endoscopic imaging systems, and rising healthcare modernization continue to support market growth.
Middle East and Africa endoscopy devices market accounted for 3.4% of the global market, totaling USD 2.10 billion in 2025, and is projected to grow at a CAGR of 6.3% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of gastrointestinal disorders, expanding access to minimally invasive procedures, and rising adoption of advanced diagnostic equipment continue to support regional market growth.
The UAE market was valued at USD 0.53 billion in 2025. Increasing investments in advanced healthcare facilities, growing medical tourism, expanding adoption of minimally invasive procedures, and rising demand for advanced diagnostic and therapeutic endoscopy systems continue to drive market growth.
Africa's market reached USD 1.57 billion in 2025. Expanding healthcare access, increasing investments in medical infrastructure, growing awareness of gastrointestinal disease diagnosis, and rising demand for minimally invasive procedures continue to create long-term growth opportunities across the region.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com